| scholarly article | Q13442814 |
| P2093 | author name string | Hongtao Zhang | |
| Yongbing Xu | |||
| Junjie Yang | |||
| Xiaoqiang Guo | |||
| Wenqing Zhao | |||
| Zeyang Wang | |||
| Yitong Li | |||
| Aixia Sui | |||
| Qilu Hu | |||
| P2860 | cites work | Histone demethylases in physiology and cancer: a tale of two enzymes, JMJD3 and UTX. | Q36936241 |
| H3K27 demethylases, at long last | Q36965110 | ||
| The future therapeutic potential of histone demethylases: A critical analysis. | Q37593487 | ||
| Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs. | Q37618835 | ||
| Epigenetics in human gliomas | Q38005274 | ||
| Understanding high grade glioma: molecular mechanism, therapy and comprehensive management | Q38075981 | ||
| Impact of H3K27 Demethylase Inhibitor GSKJ4 on NSCLC Cells Alone and in Combination with Metformin | Q38735409 | ||
| Histone demethylase JMJD3 at the intersection of cellular senescence and cancer | Q38766347 | ||
| GSKJ4, A Selective Jumonji H3K27 Demethylase Inhibitor, Effectively Targets Ovarian Cancer Stem Cells | Q38814242 | ||
| The Roles of Histone Demethylase UTX and JMJD3 (KDM6B) in Cancers: Current Progress and Future Perspectives | Q38837856 | ||
| The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs. | Q39486701 | ||
| An epigenetic therapy for diffuse intrinsic pontine gliomas. | Q48424265 | ||
| Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. | Q55456585 | ||
| Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas | Q24339074 | ||
| Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers | Q24605342 | ||
| A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response | Q27670940 | ||
| JMJD3 as an epigenetic regulator in development and disease | Q28084146 | ||
| Malignant gliomas in adults | Q29615708 | ||
| Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma | Q29616862 | ||
| Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia | Q34403179 | ||
| Targeting histone lysine demethylases - progress, challenges, and the future | Q34421279 | ||
| Expression and significance of histone H3K27 demethylases in renal cell carcinoma | Q34443684 | ||
| Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma | Q34641903 | ||
| Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer | Q35493637 | ||
| Inhibition of KDM6 activity during murine ESC differentiation induces DNA damage | Q35892322 | ||
| Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes | Q36303824 | ||
| Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma | Q36561184 | ||
| Epidemiology and molecular pathology of glioma | Q36577353 | ||
| UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia | Q36661533 | ||
| The histone demethylase jumonji coordinates cellular senescence including secretion of neural stem cell-attracting cytokines | Q36834235 | ||
| P433 | issue | 40 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 68591-68598 | |
| P577 | publication date | 2017-08-02 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | The pharmacological role of histone demethylase JMJD3 inhibitor GSK-J4 on glioma cells | |
| P478 | volume | 8 |
| Q64387216 | Assessment of epigenetic mechanisms and DNA double-strand break repair using laser micro-irradiation technique developed for hematological cells |
| Q61443106 | Comprehensive profiling of JMJD3 in gastric cancer and its influence on patient survival |
| Q58554073 | Epigenetic Targeting of Glioblastoma |
| Q96231245 | GSK-J4 induces cell cycle arrest and apoptosis via ER stress and the synergism between GSK-J4 and decitabine in acute myeloid leukemia KG-1a cells |
| Q91584664 | JMJD3 promotes the epithelial-mesenchymal transition and migration of glioma cells via the CXCL12/CXCR4 axis |
| Q89451403 | Small Molecule GSK-J1 Affects Differentiation of Specific Neuronal Subtypes in Developing Rat Retina |
| Q99419066 | Targeted inhibition of KDM6 histone demethylases eradicates tumor-initiating cells via enhancer reprogramming in colorectal cancer |
| Q93017613 | Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells |
| Q92059786 | Therapeutically targeting head and neck squamous cell carcinoma through synergistic inhibition of LSD1 and JMJD3 by TCP and GSK-J1 |
Search more.